From The Institute for Functional Medicine
In the interest of the public good, IFM supports the use of authorized COVID-19 vaccines for whom it is clinically indicated. These vaccines have been shown to decrease the likelihood of infection and associated serious sequelae or death from SARS-CoV-2 infection. For all individuals, vaccinated and unvaccinated, IFM recommends a functional medicine approach focusing on lifestyle and personalized nutrition to strengthen the immune system, address complex chronic diseases that confer increased risk, decrease the potential severity of SARS CoV-2 infection, and improve overall health. IFM promotes the active observation and testing of all COVID-19 vaccinated and unvaccinated individuals and ongoing vigilance with regard to well-established public health measures designed to reduce exposure, including masking and physical distancing.
IFM will continue to closely monitor the research and clinical experience with COVID-19 vaccines and SARS-CoV-2 infection related science. We stand firm in our mission to educate clinicians and the general public about the data surrounding COVID-19 vaccine efficacy, effectiveness, and safety. Please refer to the IFM COVID-19 vaccine resources page for our most current information and updates.
Register for IFM’s Webinar on October 7 at 5 pm PDT
IFM COVID-19 Update: Vaccines, Variants, Breakthrough Infections, Boosters, Optimizing Immune Resilience, and More
In order to continue the discussion around this important topic, IFM is presenting a free, live webinar on October 7 to update practitioners and patients regarding COVID-19. In this webinar, IFM COVID-19 Update: Vaccines, Variants, Breakthrough Infections, Boosters, Optimizing Immune Resilience, and More, expert clinicians will update attendees on the latest research on COVID-19 vaccines, including the most recent information on variants of concern and ongoing research on vaccine effectiveness (benefits) and side effects (risks). The webinar will also cover the latest on boosters, protocols for resilience, how to protect against new variants, and new data on post-acute sequelae of SARS-CoV-2 infection (PASC) in vaccinated and unvaccinated individuals. We will also answer your questions and discuss areas of concern, both known and unknown.
Join IFM COVID-19 task force members Patrick Hanaway, MD, and Joel Evans, MD, along with IFM board chair Joseph E. Pizzorno, ND, and IFM educator Tom Sult, MD, on Thursday, October 7, at 5:00 pm PDT for this live event. The panelists will also answer select attendee questions submitted ahead of time. Register now to attend the webinar and submit your questions. If you are not able to attend live, the recording will be available after the event.